View in EDS PDF Full Text

Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.

Saved in:
Bibliographic Details
Title: Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.
Alternate Title: Resistencia a antimicrobianos en bacilos gramnegativos en España: una visión de expertos.
Authors: Retamar-Gentil, Pilar1,2, Cantón, Rafael2,3, López de Medrano, Vicente Abril4, Barberán, José5, Canut Blasco, Andrés6, Dueñas Gutiérrez, Carlos7, García-Vidal, Carolina8, Larrosa Escartín, Nieves2,9, Lora-Tamayo, Jaime2,10, Martínez Marcos, Francisco Javier11, Martín Ruíz, Carlos12, Pasquau Liaño, Juan13, Rascado, Pedro14, Sanz Peláez, Óscar15, Yagüe Girao, Genoveva16, Horcajada, Juan P.2,17
Source: Revista Española de Quimioterapia. Feb2023, Vol. 36 Issue 1, p65-81. 17p.
Subjects: DRUG resistance in bacteria, BACILLUS (Bacteria), MORTALITY, COMMUNICABLE diseases
Geographic Terms: SPAIN
Abstract (English): Background. Antibiotic resistance in Gram-negative bacilli poses a serious problem for public health. In hospitals, in addition to high mortality rates, the emergence and spread of resistance to practically all antibiotics restricts therapeutic options against serious and frequent infections. Objectives. The aim of this work is to present the views of a group of experts on the following aspects regarding resistance to antimicrobial agents in Gram-negative bacilli: 1) the current epidemiology in Spain, 2) how it is related to local clinical practice and 3) new therapies in this area, based on currently available evidence. Methodology. After reviewing the most noteworthy evidence, the most relevant data on these three aspects were presented at a national meeting to 99 experts in infectious diseases, clinical microbiology, internal medicine, intensive care medicine, anaesthesiology and hospital pharmacy. Results and conclusions. Subsequent local debates among these experts led to conclusions in this matter, including the opinion that the approval of new antibiotics makes it necessary to train the specialists involved in order to optimise how they use them and improve health outcomes; microbiology laboratories in hospitals must be available throughout a continuous timetable; all antibiotics must be available when needed and it is necessary to learn to use them correctly; and the Antimicrobial Stewardship Programs (ASP) play a key role in quickly allocating the new antibiotics within the guidelines and ensure appropriate use of them. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Contexto. La resistencia a los antibióticos en bacilos gramnegativos representa un grave problema de salud pública. En el hospital, además de unas elevadas tasas de mortalidad, la aparición y propagación de resistencias a la práctica totalidad de los antibióticos limita las opciones terapéuticas frente a infecciones graves y frecuentes. Objetivos. Este trabajo tiene por objetivo dar a conocer la visión de un grupo de expertos en los siguientes aspectos respecto a la resistencia a agentes antimicrobianos en bacilos gramnegativos: 1) la epidemiología actual en España, 2) su relación con la práctica clínica local y 3) las novedades terapéuticas en este ámbito, fundamentada en la evidencia actualmente disponible. Metodología. Tras la revisión de la evidencia más destacada, los datos más relevantes de estos 3 aspectos fueron presentados en una reunión nacional ante 99 expertos en enfermedades infecciosas, microbiología clínica, medicina interna, medicina intensiva, anestesiología y farmacia hospitalaria. Resultados y conclusiones. De debates locales posteriores entre estos expertos se extrajeron conclusiones al respecto entre las que se destacan que la aprobación de nuevos antibióticos hace necesaria la formación de los especialistas implicados para optimizar su uso y mejorar los resultados en salud; los laboratorios de Microbiología de los hospitales deben estar disponibles en horario continuado; todos los antibióticos deben estar disponibles para cuando sean necesarios y se debe aprender a usarlos de forma correcta; y los Programas de Optimización del Uso de Antimicrobianos (PROA) desempeñan una labor clave en ubicar de forma ágil los nuevos antibióticos en las guías y asegurar un uso apropiado de los mismos. [ABSTRACT FROM AUTHOR]
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 161506555
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Resistencia a antimicrobianos en bacilos gramnegativos en España: una visión de expertos.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Retamar-Gentil%2C+Pilar%22">Retamar-Gentil, Pilar</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Cantón%2C+Rafael%22">Cantón, Rafael</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22López+de+Medrano%2C+Vicente+Abril%22">López de Medrano, Vicente Abril</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Barberán%2C+José%22">Barberán, José</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Canut+Blasco%2C+Andrés%22">Canut Blasco, Andrés</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Dueñas+Gutiérrez%2C+Carlos%22">Dueñas Gutiérrez, Carlos</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22García-Vidal%2C+Carolina%22">García-Vidal, Carolina</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Larrosa+Escartín%2C+Nieves%22">Larrosa Escartín, Nieves</searchLink><relatesTo>2,9</relatesTo><br /><searchLink fieldCode="AR" term="%22Lora-Tamayo%2C+Jaime%22">Lora-Tamayo, Jaime</searchLink><relatesTo>2,10</relatesTo><br /><searchLink fieldCode="AR" term="%22Martínez+Marcos%2C+Francisco+Javier%22">Martínez Marcos, Francisco Javier</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Martín+Ruíz%2C+Carlos%22">Martín Ruíz, Carlos</searchLink><relatesTo>12</relatesTo><br /><searchLink fieldCode="AR" term="%22Pasquau+Liaño%2C+Juan%22">Pasquau Liaño, Juan</searchLink><relatesTo>13</relatesTo><br /><searchLink fieldCode="AR" term="%22Rascado%2C+Pedro%22">Rascado, Pedro</searchLink><relatesTo>14</relatesTo><br /><searchLink fieldCode="AR" term="%22Sanz+Peláez%2C+Óscar%22">Sanz Peláez, Óscar</searchLink><relatesTo>15</relatesTo><br /><searchLink fieldCode="AR" term="%22Yagüe+Girao%2C+Genoveva%22">Yagüe Girao, Genoveva</searchLink><relatesTo>16</relatesTo><br /><searchLink fieldCode="AR" term="%22Horcajada%2C+Juan+P%2E%22">Horcajada, Juan P.</searchLink><relatesTo>2,17</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Revista+Española+de+Quimioterapia%22">Revista Española de Quimioterapia</searchLink>. Feb2023, Vol. 36 Issue 1, p65-81. 17p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22DRUG+resistance+in+bacteria%22">DRUG resistance in bacteria</searchLink><br /><searchLink fieldCode="DE" term="%22BACILLUS+%28Bacteria%29%22">BACILLUS (Bacteria)</searchLink><br /><searchLink fieldCode="DE" term="%22MORTALITY%22">MORTALITY</searchLink><br /><searchLink fieldCode="DE" term="%22COMMUNICABLE+diseases%22">COMMUNICABLE diseases</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22SPAIN%22">SPAIN</searchLink>
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Background. Antibiotic resistance in Gram-negative bacilli poses a serious problem for public health. In hospitals, in addition to high mortality rates, the emergence and spread of resistance to practically all antibiotics restricts therapeutic options against serious and frequent infections. Objectives. The aim of this work is to present the views of a group of experts on the following aspects regarding resistance to antimicrobial agents in Gram-negative bacilli: 1) the current epidemiology in Spain, 2) how it is related to local clinical practice and 3) new therapies in this area, based on currently available evidence. Methodology. After reviewing the most noteworthy evidence, the most relevant data on these three aspects were presented at a national meeting to 99 experts in infectious diseases, clinical microbiology, internal medicine, intensive care medicine, anaesthesiology and hospital pharmacy. Results and conclusions. Subsequent local debates among these experts led to conclusions in this matter, including the opinion that the approval of new antibiotics makes it necessary to train the specialists involved in order to optimise how they use them and improve health outcomes; microbiology laboratories in hospitals must be available throughout a continuous timetable; all antibiotics must be available when needed and it is necessary to learn to use them correctly; and the Antimicrobial Stewardship Programs (ASP) play a key role in quickly allocating the new antibiotics within the guidelines and ensure appropriate use of them. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: Contexto. La resistencia a los antibióticos en bacilos gramnegativos representa un grave problema de salud pública. En el hospital, además de unas elevadas tasas de mortalidad, la aparición y propagación de resistencias a la práctica totalidad de los antibióticos limita las opciones terapéuticas frente a infecciones graves y frecuentes. Objetivos. Este trabajo tiene por objetivo dar a conocer la visión de un grupo de expertos en los siguientes aspectos respecto a la resistencia a agentes antimicrobianos en bacilos gramnegativos: 1) la epidemiología actual en España, 2) su relación con la práctica clínica local y 3) las novedades terapéuticas en este ámbito, fundamentada en la evidencia actualmente disponible. Metodología. Tras la revisión de la evidencia más destacada, los datos más relevantes de estos 3 aspectos fueron presentados en una reunión nacional ante 99 expertos en enfermedades infecciosas, microbiología clínica, medicina interna, medicina intensiva, anestesiología y farmacia hospitalaria. Resultados y conclusiones. De debates locales posteriores entre estos expertos se extrajeron conclusiones al respecto entre las que se destacan que la aprobación de nuevos antibióticos hace necesaria la formación de los especialistas implicados para optimizar su uso y mejorar los resultados en salud; los laboratorios de Microbiología de los hospitales deben estar disponibles en horario continuado; todos los antibióticos deben estar disponibles para cuando sean necesarios y se debe aprender a usarlos de forma correcta; y los Programas de Optimización del Uso de Antimicrobianos (PROA) desempeñan una labor clave en ubicar de forma ágil los nuevos antibióticos en las guías y asegurar un uso apropiado de los mismos. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=161506555
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.37201/req/119.2022
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 17
        StartPage: 65
    Subjects:
      – SubjectFull: DRUG resistance in bacteria
        Type: general
      – SubjectFull: BACILLUS (Bacteria)
        Type: general
      – SubjectFull: MORTALITY
        Type: general
      – SubjectFull: COMMUNICABLE diseases
        Type: general
      – SubjectFull: SPAIN
        Type: general
    Titles:
      – TitleFull: Antimicrobial resistance in Gram-negative bacilli in Spain: an experts' view.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Retamar-Gentil, Pilar
      – PersonEntity:
          Name:
            NameFull: Cantón, Rafael
      – PersonEntity:
          Name:
            NameFull: López de Medrano, Vicente Abril
      – PersonEntity:
          Name:
            NameFull: Barberán, José
      – PersonEntity:
          Name:
            NameFull: Canut Blasco, Andrés
      – PersonEntity:
          Name:
            NameFull: Dueñas Gutiérrez, Carlos
      – PersonEntity:
          Name:
            NameFull: García-Vidal, Carolina
      – PersonEntity:
          Name:
            NameFull: Larrosa Escartín, Nieves
      – PersonEntity:
          Name:
            NameFull: Lora-Tamayo, Jaime
      – PersonEntity:
          Name:
            NameFull: Martínez Marcos, Francisco Javier
      – PersonEntity:
          Name:
            NameFull: Martín Ruíz, Carlos
      – PersonEntity:
          Name:
            NameFull: Pasquau Liaño, Juan
      – PersonEntity:
          Name:
            NameFull: Rascado, Pedro
      – PersonEntity:
          Name:
            NameFull: Sanz Peláez, Óscar
      – PersonEntity:
          Name:
            NameFull: Yagüe Girao, Genoveva
      – PersonEntity:
          Name:
            NameFull: Horcajada, Juan P.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 02143429
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Revista Española de Quimioterapia
              Type: main
ResultId 1